Cargando…
Plasma Sequencing for Patients with GIST—Limitations and Opportunities in an Academic Setting
SIMPLE SUMMARY: At some point during long-term treatment, gastrointestinal stromal tumors (GIST) stop responding to treatment due to new genetic changes (mutations). These mutations can be found in the blood of patients using very expensive methods not covered by insurance. We discovered that some m...
Autores principales: | Falkenhorst, Johanna, Grunewald, Susanne, Krzeciesa, Dawid, Herold, Thomas, Ketzer, Julia, Christoff, Miriam, Hamacher, Rainer, Kostbade, Karina, Treckmann, Jürgen, Köster, Johannes, Farzaliyev, Farhad, Fletcher, Benjamin Samulon, Dieckmann, Nils, Kaths, Moritz, Mühlenberg, Thomas, Schildhaus, Hans-Ulrich, Bauer, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688348/ https://www.ncbi.nlm.nih.gov/pubmed/36428589 http://dx.doi.org/10.3390/cancers14225496 |
Ejemplares similares
-
Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib
por: Falkenhorst, Johanna, et al.
Publicado: (2016) -
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology
por: Schott, Inna, et al.
Publicado: (2021) -
Inhibition of KIT-Glycosylation by 2-Deoxyglucose Abrogates KIT-Signaling and Combination with ABT-263 Synergistically Induces Apoptosis in Gastrointestinal Stromal Tumor
por: Mühlenberg, Thomas, et al.
Publicado: (2015) -
Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of Metastasectomy
por: Stork, Theresa, et al.
Publicado: (2022) -
Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)
por: Heinrich, Michael C., et al.
Publicado: (2019)